These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 19691926)

  • 1. Atherosclerosis risk factors in systemic lupus erythematosus.
    Agarwal S; Elliott JR; Manzi S
    Curr Rheumatol Rep; 2009 Aug; 11(4):241-7. PubMed ID: 19691926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atherosclerosis in Systemic Lupus Erythematosus.
    Tobin R; Patel N; Tobb K; Weber B; Mehta PK; Isiadinso I
    Curr Atheroscler Rep; 2023 Nov; 25(11):819-827. PubMed ID: 37768411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic lupus erythematosus and cardiovascular disease.
    Frostegård J
    J Intern Med; 2023 Jan; 293(1):48-62. PubMed ID: 35982610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding Accelerated Atherosclerosis in Systemic Lupus Erythematosus: Toward Better Treatment and Prevention.
    Reiss AB; Jacob B; Ahmed S; Carsons SE; DeLeon J
    Inflammation; 2021 Oct; 44(5):1663-1682. PubMed ID: 33821395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Atherosclerosis in systemic lupus erythematosus].
    Tazi Mezalek Z; Harmouche H; Ammouri W; Maamar M; Adnaoui M; Cacoub P
    Presse Med; 2014 Oct; 43(10 Pt 1):1034-47. PubMed ID: 25201598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Accelerated atherosclerosis and inflammation in systemic lupus erythematosus].
    Funakubo Asanuma Y
    Nihon Rinsho Meneki Gakkai Kaishi; 2012; 35(6):470-80. PubMed ID: 23291482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atherosclerosis in systemic lupus erythematosus.
    Sherer Y; Zinger H; Shoenfeld Y
    Autoimmunity; 2010 Feb; 43(1):98-102. PubMed ID: 20014976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Excess atherosclerosis in systemic lupus erythematosus,-A matter of renal involvement: Case control study of 281 SLE patients and 281 individually matched population controls.
    Gustafsson JT; Herlitz Lindberg M; Gunnarsson I; Pettersson S; Elvin K; Öhrvik J; Larsson A; Jensen-Urstad K; Svenungsson E
    PLoS One; 2017; 12(4):e0174572. PubMed ID: 28414714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Definitions of and contributions to cardiovascular disease in systemic lupus erythematosus.
    Gustafsson JT; Svenungsson E
    Autoimmunity; 2014 Mar; 47(2):67-76. PubMed ID: 24228980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular disease in systemic lupus erythematosus: an update.
    Liu Y; Kaplan MJ
    Curr Opin Rheumatol; 2018 Sep; 30(5):441-448. PubMed ID: 29870498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SLE, atherosclerosis and cardiovascular disease.
    Frostegård J
    J Intern Med; 2005 Jun; 257(6):485-95. PubMed ID: 15910552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelial Dysfunction in Systemic Lupus Erythematosus: Pathogenesis, Assessment and Therapeutic Opportunities.
    Mauro D; Nerviani A
    Rev Recent Clin Trials; 2018; 13(3):192-198. PubMed ID: 29542419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-Traditional Pro-Inflammatory and Pro-Atherosclerotic Risk Factors Related to Systemic Lupus Erythematosus.
    Richter P; Cardoneanu A; Rezus C; Burlui AM; Rezus E
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-density lipoprotein functionality in systemic lupus erythematosus.
    Ganjali S; Shirmohammadi L; Read MI; Sahebkar A
    Semin Arthritis Rheum; 2020 Aug; 50(4):769-775. PubMed ID: 32531506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanistic insight into premature atherosclerosis and cardiovascular complications in systemic lupus erythematosus.
    Liu Y; Yu X; Zhang W; Zhang X; Wang M; Ji F
    J Autoimmun; 2022 Oct; 132():102863. PubMed ID: 35853760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenic immunity in systemic lupus erythematosus and atherosclerosis: common mechanisms and possible targets for intervention.
    Wigren M; Nilsson J; Kaplan MJ
    J Intern Med; 2015 Nov; 278(5):494-506. PubMed ID: 25720452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Innate Immune Dysregulation in the Development of Cardiovascular Disease in Lupus.
    Tumurkhuu G; Montano E; Jefferies C
    Curr Rheumatol Rep; 2019 Jul; 21(9):46. PubMed ID: 31338604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Traditional and nontraditional risk factors for atherosclerosis in patients with systemic lupus erythematosus.
    Pompilian V; Badea C; Dragomanu I; Bălăşescu E; Tănăsescu C
    Rom J Intern Med; 2008; 46(3):195-8. PubMed ID: 19366077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atherosclerosis and systemic lupus erythematosus: mechanistic basis of the association.
    McMahon M; Hahn BH
    Curr Opin Immunol; 2007 Dec; 19(6):633-9. PubMed ID: 18083018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutrophil subsets and their gene signature associate with vascular inflammation and coronary atherosclerosis in lupus.
    Carlucci PM; Purmalek MM; Dey AK; Temesgen-Oyelakin Y; Sakhardande S; Joshi AA; Lerman JB; Fike A; Davis M; Chung JH; Playford MP; Naqi M; Mistry P; Gutierrez-Cruz G; Dell'Orso S; Naz F; Salahuddin T; Natarajan B; Manna Z; Tsai WL; Gupta S; Grayson P; Teague H; Chen MY; Sun HW; Hasni S; Mehta NN; Kaplan MJ
    JCI Insight; 2018 Apr; 3(8):. PubMed ID: 29669944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.